If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
You need a JavaScript-enabled browser to view this Publication
Please follow these steps to view the Publication:
Enable JavaScript in your browser
Refresh this page
Best regards
Zmags
GASTROENTEROLOGY
EMJ Gastroenterol. 2019 Suppl 2 • europeanmedical-journal.com
INSIDE
Key Considerations in the Management
of Inflammatory Bowel Disease:
Interviews with Key Opinion Leaders
Supported by Fresenius Kabi
Key Considerations in the Management
of Inflammatory Bowel Disease:
Interviews with Key Opinion Leaders
Interviewees: Ian Arnott,1 Manuel Barreiro-de Acosta,2 Eduard Stange,3 Antonio
Tursi,4 Frank Ruemmele5
1. Western General Hospital, Edinburgh, UK
2. Gastroenterology Department, Inflammatory Bowel Disease Unit, University
Hospital of Santiago de Compostela, Santiago de Compostela, Spain
3. Internal Medicine I - Gastroenterology, Hepatology and Infectious diseases,
University of Tübingen, Tübingen, Germany
4. Gastroenterology Service, Azienda Sanitaria Locale Barletta Andria Trani,
GASTROENTEROLOGY EMJ Gastroenterol. 2019 Suppl 2
Key Considerations in the Management of In
For this article, the European Medical Journal co
“Our decisions are increasingly going to be drive
often extremely limited. In this context, physici
with steroid-dependent or resistant disease.
Prof Stange added: “In those patients who have ha
look at antibodies here; if you have antibodies t
which we can detect,” stated Dr Barreiro-de
To successfully manage weight loss and
Dr Manuel Barreiro-de Acosta Gastroenterology Dep